Abdel Moneam et al. Outcome of Integrated motivational interviewing and CBT Egyptian

Q: What treatment comparison does the outcome analysis focus on?

The analysis compares MICBT with an alternative NA condition across baseline and follow-up outcomes.

Q: Which baseline and clinical variables are examined in relation to outcomes?

Demographic factors and clinical characteristics are assessed, including personality disorder status and ASI severity across psychiatric, medical, drug, employment, family, and legal domains.

Q: How do the models evaluate changes over time after treatment?

Logistic models assess predictors of nonuse at 3 and 6 months, while fixed-effects estimates test treatment group effects and time-related changes, including early follow-up periods.

Sep 2, 2026

Upload by Jacob

Outcome analysis compares MICBT with an alternative NA condition across baseline demographics and clinical characteristics, including personality disorder status and ASI severity domains (psychiatric, medical, drug, employment, family, and legal). Statistical results report group differences and longitudinal fixed effects, with attendance and time showing significant associations with outcomes. Logistic models additionally evaluate predictors of continued use versus nonuse over 3 and 6 months, highlighting the role of treatment mode and ASI family severity.

LanguageEnglish

CategoryResearch & Report

FormatPDF

Pages12

Reading Time30 min

AccessFree to download

Results

Baseline demographics and clinical characteristics

Logistic models predicting nonuse

Survival/Cox model estimates

Fixed effects over time

| | | MICBT | | NA | Test | P value | | --- | --- | --- | --- | --- | --- | --- | | Demographic data Age (years) | Range | 18–45 | | 18–43 | .313 b | .755 | | Education, n (%) | Mean ± SD Illiterate Educated Literacy education Primary/prep Technical
Secondary Intermediate High Medical | 30.83 ± 7.742 7a (23.3%) 23a (76.7%)
4 (13.3%)
3 (10 . 0%)
6 (20 . 0%) 1 (3 . 3%)
1 (3 . 3%) 6 (20 . 0%) 2 (6 . 7%) | | 30.23 ± 7.089 5a (16.7%) 25a (83.3%)
6 (20 . 0%)
3 (10 . 0%)
5 (16 . 7%) 2 (6 . 7%) 6 (20 . 0%) 2 (6 . 7%)
1 (3 . 3%) | 7.062a | .452 | | Employment, n (%) | Unemployed Employed | 18a (60.0%)
12a (40.0%) | | 15a (50.0%)
15a (50.0%) | .606a | .436 | | Marital, n (%) | Single Married
Divorced | 8 (26 . 7%)
13 (43 . 3%)
9 (30 . 0%) | | 7 (23 . 3%)
11 (36 . 7%)
12 (40 . 0%) | .662a | .718 | | Clinical characteristics of patients Personality Disorders, n (%) (SCID II) | No personality disorder Borderline
Depressive
Dependent
Avoidant
Obsessive
Paranoid | 9 (30 . 0%)
3 (10 . 0%)
6 (20 . 0%)
4 (13.3%)
6 (20 . 0%)
1 (3 . 3%)
1 (3 . 3%) | | 11 (36 . 7%)
2 (6 . 7%)
5 (16 . 7%)
4 (13.3%)
4 (13.3%)
1 (3 . 3%)
3 (10 . 0%) | 1.891a | .944 | | Age at onset (years) (FORM 90) | Range | 15–30 | | 14–33 | ‑1.794b | .078 | | Lifetime duration of drug use (weeks)(FORM 90)
ASI (composite score) | Mean ± SD Range Mean ± SD | 20.60 ± 3.645 50–780
305.93 ± 194.780 | | 22.87 ± 5.077 45–520
263.80 ± 141.617 | .958b | .342 | | | ASI Psychiatry | Mean ± SD
Median | .39 ± .15 .40 | .35 ± .14 .40 | 498.5c | .460 | | | ASI MED | Mean ± SD
Median | .61 ± .17 .60 | .54 ± .16 .55 | 561.00c | .095 | | | ASI EMPL | Mean ± SD
Median | .54 ± .24 .50 | .50 ± .22 .45 | 496.50c | .488 | | | ASI DRUG | Mean ± SD
Median | .75 ± .14 .80 | .75 ± .12 .80 | 455.00c | .939 | | | ASI FAM | Mean ± SD
Median | .58 ± .20 .60 | .59 ± .23 .55 | 441.5c | .899 | | | ASI LEG | Mean ± SD
Median | .20 ± .09 .20 | .25 ± .13 .20 | 368.5c | .205 | | Parameter | Days of use among all participants (count portion) | | | Logistic portion predicting nonuse | | | | --- | --- | --- | --- | --- | --- | --- | | | B (SE) | P | IRR | B (SE) | P | OR | | 3 months | | | | | | | | Intercept | 2.40 (0 . 61) | < . 001** | 10.72 | 4.66 (3 . 09) | 0.13 | 105.9 | | Mode of treatment (MICBT) | − 0.35 (0 . 13) | 0.006* | 0.71 | 2.55 (0 . 86) | 0.003* | 12.85 | | Age | 0.013 (0 . 009) | 0.15 | 1.01 | 0.06 (0 . 05) | 0.23 | 1.06 | | Personality disorder | − 0.22 (0 . 17) | 0.21 | 0.79 | 2.45 (1 . 57) | 0.12 | 11.62 | | Education, educated = 1 | 0.11 (0 . 14) | 0.44 | 1.11 | 0.89 (1 . 10) | 0.41 | 2.44 | | ASI severity of psychiatric problems | 0.11 (0 . 05) | 0.02* | 1.11 | − .65 (0 . 50) | 0.19 | 0.52 | | ASI severity of medical problems | 0.01 (0 . 04) | 0.73 | 1.01 | − .27 (0 . 37) | 0.46 | 0.75 | | ASI severity of drug problems | − 0.02 (0 . 06) | 0.68 | 0.96 | − .24 (0.40) | 0.54 | 0.78 | | ASI severity of employment problems | − 0.07 (0 . 04) | 0.04 | 0.92 | − .23 (0 . 25) | 0.37 | 0.79 | | ASI severity of family problems | 0.21 (0 . 03) | < . 001** | 0.96 | − .70 (0 . 26) | 0.009* | 0.49 | | Log (theta)
6 months | 2.60 (0 . 33) | < . 001** | | | | | | Intercept | 3.15 (0 . 32) | < . 001** | 21.47 | 1.56 (3 . 06) | 0.60 | 4.79 | | Mode of treatment MICBT = 1 | − 0.33 (0 . 07) | < . 001** | 0.70 | 2.83 (1 . 06) | 0.008* | 16.99 | | Age | 0.002 (0 . 005) | 0.73 | 1.001 | 0.06 (0 . 05) | 0.26 | 1.06 | | Personality disorder | − 0.31 (0 . 10) | 0.002* | 0.69 | − 0.67 (1 .46) | 0.64 | 0.50 | | Education, educated = 1 | − 0.05 (0 . 08) | 0.47 | 0.94 | 1.67 (1 . 37) | 0.22 | 5.32 | | ASI severity of psychiatric problems | 0.08 (0 . 03) | 0.006 | 1.09 | − .10 (0 .49) | 0.83 | 0.89 | | ASI severity of medical problems | 0.02 (0 . 02) | 0.43 | 1.02 | − .62 (0 .46) | 0.17 | 0.53 | | ASI severity of drug problems | 0.007 (0 . 04) | 0.85 | 1.01 | − .032 (0 .4

FAQs

What treatment comparison does the outcome analysis focus on?

The analysis compares MICBT with an alternative NA condition across baseline and follow-up outcomes.

Which baseline and clinical variables are examined in relation to outcomes?

Demographic factors and clinical characteristics are assessed, including personality disorder status and ASI severity across psychiatric, medical, drug, employment, family, and legal domains.

How do the models evaluate changes over time after treatment?

Logistic models assess predictors of nonuse at 3 and 6 months, while fixed-effects estimates test treatment group effects and time-related changes, including early follow-up periods.

Sep 2, 2026

Upload by Jacob